From: Can the vector space model be used to identify biological entity activities?
Subnetwork | Dimensional Space | Interaction | Level in 2005 | Level in 2004 | Patents in 2005 | Patents in 2004 |
---|---|---|---|---|---|---|
5 | disease gene | heart attack ppar-gamma | 0.9999 | 0.8324 | 1 | 61 |
1 | target disease | adrenaline cardiac ischemia | 0.9866 | 0.8676 | 1 | 36 |
11 | target disease drug gene | hmg coa reduct. breast cancer tamoxifen kennedy disease | 0.9190 | 0.6383 | 1 | 5 |
2 | target drug | gp iib/iiia neoral | 0.9137 | 0.8354 | 1 | 103 |
4 | disease drug | HIV bonyl | 0.9041 | 0.8825 | 1 | 30 |